Early outcomes of transcatheter arterial embolization using imipenem/cilastatin for plantar fasciitis refractory to conservative therapy.
Rozil Gandhi, Mohal Banker
https://pubmed.ncbi.nlm.nih.gov/38281074Actively Recruiting
Led by IR Centers · Updated on 2025-02-03
10
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the safety and feasibility of using Lipiodol (ethiodized oil) as an investigational embolic agent to treat pain caused by plantar fasciitis. This study focuses on a minimally invasive procedure called plantar fascia embolization (PFE), aiming to reduce inflammation and pain in the heel area. The study will assess changes in pain levels and foot function over a six-month period following treatment. Participants will receive plantar fascia embolization using Lipiodol, which targets the blood vessels in the plantar fascia to reduce inflammation and pain. This study involves a single intervention group receiving this treatment. The procedure is designed to be minimally invasive and is administered once during the study period. During the study, participants will be monitored for changes in pain using the Visual Analog Scale (VAS) and improvements in foot function using the Foot and Ankle Ability Measure (FAAM). Researchers will also watch for any side effects or safety concerns related to the treatment. The follow-up period lasts six months, allowing for thorough assessment of outcomes and participant well-being throughout the study.
CONDITIONS
Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single procedure with follow-up assessments up to 6 months
Participants receive plantar fascia embolization using Lipiodol (ethiodized oil) to treat heel pain caused by plantar fasciitis.
1 procedure visit and multiple follow-up visits over 6 months
Total: 1 location
1
IR Centers
Falls Church, Virginia, United States, 22043
Actively Recruiting
S
Sindhuja Kommidi Clinical Research Coordinator, MS
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rozil Gandhi, Mohal Banker
https://pubmed.ncbi.nlm.nih.gov/38281074Takahide Sasaki, Masahiko Shibuya, Koichi Miyazaki...
https://pubmed.ncbi.nlm.nih.gov/39089905Marc Sapoval, Charles Querub, Helena Pereira...
https://pubmed.ncbi.nlm.nih.gov/38102013